TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21385401

Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention (daily self-measurements of respiratory-rate, heart-rate, blood pressure, oxygen saturation, weight, body temperature; daily qualitative symptom questionnaire; routine telephone contacts every fortnight)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study: 19710679

Group type: EXPERIMENTAL
Intervention: 0.25% chlorhexidine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 60

Group type: COMPARATOR
Intervention: No skin cleansing
Number of subjects: 60
Study: 17261216

Group type: EXPERIMENTAL
Intervention: Combination of pretreatment of remifentanil (0.35 microg kg(‐1) min(‐1)) and premixture of lidocaine with propofol (1% propofol and 1% lidocaine in a 10:1 ratio)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Remifentanil pretreatment (0.35 microg kg(‐1) min(‐1))
Number of subjects: 141

Group type: COMPARATOR
Intervention: Lidocaine premixture with propofol
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Combination therapy (remifentanil and lidocaine)
Number of subjects: 141
Study: 14871466

Group type: EXPERIMENTAL
Intervention: anti-TNF-alpha humanized antibodies (infliximab)
Number of subjects: 98

Group type: COMPARATOR
Intervention: soluble cytokine
Number of subjects: 98

Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 98
Study: 11728350

Group type: EXPERIMENTAL
Intervention: Tenecteplase (TNK)
Number of subjects: 0

Group type: COMPARATOR
Intervention: tissue plasminogen activator (t-PA)
Number of subjects: 0
Study: 9210852

Group type: EXPERIMENTAL
Intervention: Older adults performing lexical tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single lexical decision and category judgment tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantic priming effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All old subgroups (fast, medium, slow)
Number of subjects: 0
Study: 7970234

Group type: EXPERIMENTAL
Intervention: Apolipoprotein E epsilon 4 allele frequency in Lewy body dementia (LBD)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Apolipoprotein E epsilon 4 allele frequency in Alzheimer's disease (AD)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (non-demented)
Number of subjects: 154
Study: 3115846

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate transdermal patch (10 mg daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30946269

Group type: EXPERIMENTAL
Intervention: Weighted vest running (WVR) with 10% body mass (BM)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Weighted vest running (WVR) with 5% body mass (BM)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (no vest)
Number of subjects: 17
Study: 31170299

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Traditional Vocational Rehabilitation (TVR)
Number of subjects: 96
Study: 29125384

Group type: EXPERIMENTAL
Intervention: Prehabilitation exercise
Number of subjects: 0
Study: 27209333

Group type: EXPERIMENTAL
Intervention: Mobilization on the day of surgery
Number of subjects: 126

Group type: COMPARATOR
Intervention: Mobilization on the day after surgery
Number of subjects: 126
Study: 24625415

Group type: EXPERIMENTAL
Intervention: BCLU morphology
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: MYC protein expression
Number of subjects: 260

Group type: COMPARATOR
Intervention: Typical DLBCL morphology
Number of subjects: 260
Study: 23237915

Group type: EXPERIMENTAL
Intervention: BungeeSkate training
Number of subjects: 20
Study: 20056443

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional one-lung ventilation (OLV) using double-lumen tubes (DLT)
Number of subjects: 40
Study: 19539353

Group type: EXPERIMENTAL
Intervention: IA-BioHA (20 mg/2 ml)
Number of subjects: 588

Group type: COMPARATOR
Intervention: IA-SA (buffered saline)
Number of subjects: 588

Group type: COMPARATOR
Intervention: IA-BioHA vs IA-SA
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: IA-BioHA
Number of subjects: 588

Group type: COMPARATOR
Intervention: IA-SA
Number of subjects: 588
Study: 16106139

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent without lesion predilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent after lesion predilation
Number of subjects: 0
Study: 11844646

Group type: EXPERIMENTAL
Intervention: Comprehensive information on the importance of mobilization, balanced anesthesia, and postoperative analgesia including epidural local anesthetics and enforced postoperative mobilization
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group receiving anesthesia without epidural local anesthetics, postoperative analgesia with epidural morphine, and mobilization without fixed goals
Number of subjects: 40
Study: 10069276

Group type: EXPERIMENTAL
Intervention: Sufentanil concentration of 1.5 ng/mL (group L)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Sufentanil concentration of 3.0 ng/mL (group M)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Sufentanil concentration of 4.5 ng/mL (group H)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Sufentanil concentrations (all groups)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Sufentanil concentration of 1.7 ng/mL
Number of subjects: 39
Study: 7628181

Group type: EXPERIMENTAL
Intervention: 0.03 mg/kg midazolam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.07 mg/kg midazolam
Number of subjects: 12

Group type: COMPARATOR
Intervention: 0.1 mg/kg diazepam
Number of subjects: 12

Group type: COMPARATOR
Intervention: 0.2 mg/kg diazepam
Number of subjects: 12
Study: 2023732

Group type: EXPERIMENTAL
Intervention: Post-vitrectomy
Number of subjects: 98

Group type: COMPARATOR
Intervention: No vitrectomy (control)
Number of subjects: 98
Study: 7034592

Group type: EXPERIMENTAL
Intervention: 200 mg buflomedil
Number of subjects: 10

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 10
Study: 31858732

Group type: EXPERIMENTAL
Intervention: Large Changes (LC; lose 5-10 pounds initially)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Small Changes (SC; make small daily changes in intake and activity)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Control
Number of subjects: 599
Study: 31323662

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 1116
Study: 28587607

Group type: EXPERIMENTAL
Intervention: Standard care plus feedback based on questionnaire results
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 150
Study: 25918933

Group type: EXPERIMENTAL
Intervention: Curcumin (45 mg/day) for 14 days before surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24983280

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 257

Group type: COMPARATOR
Intervention: Carbamazepine and Venlafaxine
Number of subjects: 257
Study: 22017967

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (community-based group exercise sessions, instructed home exercise, dietary counselling)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 190
Study: 19237785

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 45

Group type: COMPARATOR
Intervention: Two-stage adjustable suture technique
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Single-stage adjustable strabismus surgery (SSASS) under topical anesthesia and intravenous conscious sedation
Number of subjects: 45
Study: 17076222

Group type: EXPERIMENTAL
Intervention: Special exercise program (moderate exercise for maximum 1 hour 3 times a week for a year)
Number of subjects: 373

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 373
Study: 14660132

Group type: EXPERIMENTAL
Intervention: Naloxone bolus administered under anaesthetic
Number of subjects: 48
Study: 10783370

Group type: EXPERIMENTAL
Intervention: Misoprostol with water (group 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Misoprostol alone (group 2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 9032593

Group type: EXPERIMENTAL
Intervention: Fluconazole + recombinant human granulocyte colony stimulating factor (rhG‐CSF)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Fluconazole monotherapy
Number of subjects: 111
Study: 1355923

Group type: EXPERIMENTAL
Intervention: Idazoxan (20 mg, 40 mg, 80 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yohimbine (20 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6497745

Group type: EXPERIMENTAL
Intervention: Flurbiprofen sodium 0.03%
Number of subjects: 118

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 118
Study: 30146783

Group type: EXPERIMENTAL
Intervention: Nitrogen plasma treatment on one side of periorbital wrinkles with three sessions at a three-week interval
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nitrogen plasma treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (contralateral side without treatment)
Number of subjects: 18
Study: 29743162

Group type: EXPERIMENTAL
Intervention: Short telomere length (measured ≤5 years before diagnosis)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Short chromosome 5p telomere length
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Short chromosome 13q telomere length
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: All-cause mortality patterns
Number of subjects: 788
Study: 27701661

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA (200 U, cystoscopic intradetrusor injection)
Number of subjects: 381

Group type: COMPARATOR
Intervention: Sacral neuromodulation
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA
Number of subjects: 381
Study: 25000668

Group type: EXPERIMENTAL
Intervention: Test dentifrice containing 1.5% arginine, an insoluble calcium compound and 1,450 ppm fluoride
Number of subjects: 48

Group type: COMPARATOR
Intervention: Commercial silica dentifrice with 1,450 ppm fluoride as sodium fluoride (NaF)
Number of subjects: 48
Study: 22174350

Group type: EXPERIMENTAL
Intervention: PACAP38 (10 pmol/kg/min for 20 minutes)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg subcutaneously)
Number of subjects: 14
Study: 20402845

Group type: COMPARATOR
Intervention: EMLA (for 60 min)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ametop (for 60 min)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rapydan (for 30 min)
Number of subjects: 20
Study: 17540991

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 15802487

Group type: EXPERIMENTAL
Intervention: Context sensitive, visibly highlighted, selectable hyperlinks for educational decision support features
Number of subjects: 779

Group type: COMPARATOR
Intervention: Standard CPOE interface with menu access to decision support
Number of subjects: 779
Study: 11844821

Group type: EXPERIMENTAL
Intervention: Orally administered eniluracil and 5-FU (1.0 mg/m2 with eniluracil in a 10:1 ratio, twice daily for 28 days)
Number of subjects: 84
Study: 10544991

Group type: EXPERIMENTAL
Intervention: Integrated drug and alcohol intervention (IDAI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimal intervention condition (MI)
Number of subjects: 0
Study: 8815652

Group type: EXPERIMENTAL
Intervention: Piezoelectric lithotripter
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Electrohydraulic lithotripter
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 18
Study: 1691416

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0
Study: 108739

Group type: EXPERIMENTAL
Intervention: Limbitrol
Number of subjects: 279

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 279

Group type: COMPARATOR
Intervention: Chlordiazepoxide
Number of subjects: 279
Study: 30975525

Group type: EXPERIMENTAL
Intervention: PCV10 (3+1 schedule, group A)
Number of subjects: 1201

Group type: EXPERIMENTAL
Intervention: PCV10 (3+0 schedule, group B)
Number of subjects: 1201

Group type: EXPERIMENTAL
Intervention: PCV10 (2+1 schedule, group C)
Number of subjects: 1201

Group type: EXPERIMENTAL
Intervention: PCV10 (two-dose schedule, group D)
Number of subjects: 1201

Group type: EXPERIMENTAL
Intervention: PCV13 (2+1 schedule, group E)
Number of subjects: 1201

Group type: COMPARATOR
Intervention: No infant PCV (control, group F)
Number of subjects: 1201
Study: 27753182

Group type: EXPERIMENTAL
Intervention: transdermal oestradiol (tE2)
Number of subjects: 727

Group type: COMPARATOR
Intervention: luteinising hormone-releasing hormone agonists (LHRHa)
Number of subjects: 727
Study: 24678746

Group type: EXPERIMENTAL
Intervention: Povidone iodine 2.5% solution irrigation
Number of subjects: 35

Group type: COMPARATOR
Intervention: Preservative-free artificial tears and preservative-free antibiotic drops (without povidone iodine)
Number of subjects: 35
Study: 23488588

Group type: EXPERIMENTAL
Intervention: Adolescents with psychopathic traits
Number of subjects: 35

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 35
Study: 21276812

Group type: EXPERIMENTAL
Intervention: Physical Activity Leaders (PALs) program
Number of subjects: 100
Study: 19700221

Group type: EXPERIMENTAL
Intervention: Bondable reinforcement ribbon
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Light‐cured composite
Number of subjects: 25

Group type: COMPARATOR
Intervention: Periodontal pack
Number of subjects: 25

Group type: COMPARATOR
Intervention: Wire
Number of subjects: 25

Group type: COMPARATOR
Intervention: Calcium hydroxide paste
Number of subjects: 25
Study: 16371732

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 6477

Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 6477
Study: 12972114

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10713313

Group type: EXPERIMENTAL
Intervention: 3.8 g eicosapentaenoic acid/d
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: 3.6 g docosahexaenoic acid/d
Number of subjects: 224

Group type: COMPARATOR
Intervention: 4.0 g corn oil/d (placebo)
Number of subjects: 224
Study: 8811760

Group type: EXPERIMENTAL
Intervention: General practice follow up
Number of subjects: 296

Group type: COMPARATOR
Intervention: Hospital follow up
Number of subjects: 296
Study: 1393483

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Open appendicectomy
Number of subjects: 65
Study: 2867396

Group type: EXPERIMENTAL
Intervention: Oral immunisation with killed Haemophilus influenzae
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31252161

Group type: EXPERIMENTAL
Intervention: Dawn-Dusk Simulator (DDS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no DDS)
Number of subjects: 20
Study: 29280191

Group type: EXPERIMENTAL
Intervention: Nutritional supplements (at least 50% of the recommended dose)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Nutritional supplements
Number of subjects: 164
Study: 27594841

Group type: EXPERIMENTAL
Intervention: Active Mandibular Advancement Splint (Twin-block)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham Mandibular Advancement Splint
Number of subjects: 16
Study: 24853829

Group type: EXPERIMENTAL
Intervention: Serial clopidogrel dose adjustment based on platelet function testing (PFT) during 12 months of dual antiplatelet therapy (DAPT). Patients took up to two additional 600 mg loading doses and a maintenance dose of 75-300 mg.
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (standard treatment without dose adjustment).
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control).
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Interventional group (with dose adjustment).
Number of subjects: 87
Study: 22992417

Group type: EXPERIMENTAL
Intervention: Implementation salvage strategies used during the trial
Number of subjects: 0
Study: 20562076

Group type: EXPERIMENTAL
Intervention: 50 IU/kg heparin with an upper limit of 5,000 IU
Number of subjects: 162

Group type: COMPARATOR
Intervention: 5,000 IU heparin (standard dose)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 50 IU/kg heparin
Number of subjects: 162
Study: 17722960

Group type: COMPARATOR
Intervention: Intranasal fluticasone furoate 110 microg once daily for 2 weeks in adults and adolescents with seasonal allergic rhinitis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intranasal fluticasone furoate 110 microg once daily for 4-6 weeks in adults and adolescents with perennial allergic rhinitis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intranasal fluticasone furoate nasal spray in children aged 6-11 years for 2 weeks for seasonal allergic rhinitis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intranasal fluticasone furoate nasal spray in children aged 6-11 years for 4 weeks for perennial allergic rhinitis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluticasone furoate nasal spray in adults, adolescents and children aged 2-11 years
Number of subjects: 0
Study: 15792815

Group type: EXPERIMENTAL
Intervention: 1500 mcg mecobalamin daily for 2 years
Number of subjects: 135

Group type: COMPARATOR
Intervention: Untreated group (no mecobalamin)
Number of subjects: 135
Study: 11865276

Group type: EXPERIMENTAL
Intervention: Dextranomer/hyaluronic acid copolymer
Number of subjects: 61

Group type: COMPARATOR
Intervention: Antibiotic prophylaxis
Number of subjects: 61
Study: 11257272

Group type: EXPERIMENTAL
Intervention: CD14 C(‐260)T gene polymorphism
Number of subjects: 14916

Group type: COMPARATOR
Intervention: Control group (age‐ and smoking‐matched participants who remained free of vascular diseases)
Number of subjects: 14916
Study: 11367647

Group type: EXPERIMENTAL
Intervention: Xuefuzhuyu Pill (XFZYP) 6 g, three times daily for one month
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Xuefuzhuyu Pill (XFZYP)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Aspirin 40 mg per day for one month
Number of subjects: 57
Study: 8158883

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 18

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 18
Study: 3142509

Group type: EXPERIMENTAL
Intervention: Alfentanil priming infusion (60 micrograms kg‐1 min‐1 for 10 min) followed by maintenance infusion (4.5 micrograms kg‐1 min‐1) with lorazepam 0.08 mg kg‐1 by mouth 1-2 h before operation.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Alfentanil maintenance infusion rates of 5.4 (n = 4), 6.6 (n = 5), or 7.8 (n = 4) micrograms kg‐1 min‐1, each preceded by a proportional priming infusion with lorazepam 0.04 mg kg‐1 by mouth as premedication.
Number of subjects: 19
Study: 29316106

Group type: EXPERIMENTAL
Intervention: Robotic-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Robotic-assisted radical cystectomy (RARC)
Number of subjects: 39
Study: 28536866

Group type: EXPERIMENTAL
Intervention: Quetiapine-XR
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 26209742

Group type: EXPERIMENTAL
Intervention: Healthiest tertile of the modified Alternate Healthy Eating Index (mAHEI) score
Number of subjects: 3088

Group type: EXPERIMENTAL
Intervention: Suboptimal dietary quality (mAHEI < 28) improved to mAHEI of 28
Number of subjects: 3088

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 3088
Study: 24278313

Group type: EXPERIMENTAL
Intervention: Motivation session (MEG recording during imagery of maximum grips)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control session (MEG recording during imagery of maximum grips)
Number of subjects: 12
Study: 21176724

Group type: EXPERIMENTAL
Intervention: Erdosteine (E) 300 mg b.i.d. for 10 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (P) for 10 days
Number of subjects: 12
Study: 18339162

Group type: COMPARATOR
Intervention: Propofol 1 mg/kg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Propofol 0.5 mg/kg and ketamine 0.5 mg/kg
Number of subjects: 47
Study: 17162282

Group type: EXPERIMENTAL
Intervention: Crystalloid cardioplegia (Group 1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Blood cardioplegia (Group 2)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 40
Study: 14584380

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation
Number of subjects: 167

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study: 10926377

Group type: EXPERIMENTAL
Intervention: 4 puffs (0.4 mg) via MDI with spacer
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 10 puffs (1.0 mg) via MDI with spacer
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 2.5 mg via SVN
Number of subjects: 13
Study: 8817987

Group type: EXPERIMENTAL
Intervention: Biventricular bypass (BVB) with oxygenation
Number of subjects: 17
Study: 14621850

Group type: EXPERIMENTAL
Intervention: OKT3 (5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ATG (dependent on body weight)
Number of subjects: 0
Study: 28657810

Group type: EXPERIMENTAL
Intervention: Stand-up paddle practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Walking control group
Number of subjects: 0
Study: 26671484

Group type: EXPERIMENTAL
Intervention: Intralipid
Number of subjects: 154

Group type: COMPARATOR
Intervention: IVIG
Number of subjects: 154
Study: 26673577

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 125 mg/m2 plus gemcitabine 1000 mg/m2
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 125 mg/m2 plus carboplatin area under the curve 2 mg×min/mL
Number of subjects: 240

Group type: COMPARATOR
Intervention: gemcitabine 1000 mg/m2 plus carboplatin area under the curve 2 mg×min/mL
Number of subjects: 240
Study: 23780578

Group type: EXPERIMENTAL
Intervention: Renal sympathetic denervation (RDN)
Number of subjects: 346